Haematological cancer: MRD assessment - guiding decisions for patients with AML
- PMID: 26856743
- DOI: 10.1038/nrclinonc.2016.16
Haematological cancer: MRD assessment - guiding decisions for patients with AML
Comment on
-
Assessment of Minimal Residual Disease in Standard-Risk AML.N Engl J Med. 2016 Feb 4;374(5):422-33. doi: 10.1056/NEJMoa1507471. Epub 2016 Jan 20. N Engl J Med. 2016. PMID: 26789727 Clinical Trial.
References
-
- N Engl J Med. 2016 Feb 4;374(5):422-33 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
